SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation into Whether the Sale of Sequenom Inc. to Laboratory Corporation of America Holdings for $2.40 Per Share is Fair to Shareholders – SQNM

NEW YORK, NY / ACCESSWIRE / July 27, 2016 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Sequenom Inc. (“Sequenom”) (NASDAQ: SQNM) stock prior to July 27, 2016.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Sequenom to Laboratory Corporation of America Holdings (NYSE: LH) for $2.40 per share. To learn more about the action and your rights, go to: http://zlk.9nl.com/sequenom-sqnm or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 442907